Company intelligence / Profile preview

Peninsula Laboratories International

San Carlos, California, United Statesbma.ch ↗

Ownership: Private
Development stage: Commercial

Overview

Peninsula Laboratories International provided a wide range of high-quality immunoassays, antibodies, and related products for the life sciences research community over more than 40 years. The company was recognized for its expertise in enzyme immunoassays and radioimmunoassays before its business was transferred to BMA Biomedicals.

Therapeutic areas: Other
Modalities: AntibodyEnzyme immunoassay kit (EIA/ELISA)Radioimmunoassay kit (RIA)Polyclonal antibodyMonoclonal antibody
Industry: Non-Drug Biotech

Partnerships

BMA Biomedicals (current distributor/owner of product lines)

Beyond the preview

Go deeper on Peninsula Laboratories International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peninsula Laboratories International.

Explore the full profile